SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Globalisation

Medpace moves into Singapore with new central lab

07-May-2014 - Medpace Laboratories, Singapore will serve and support new and existing Medpace pharmaceutical clients conducting clinical research in the rapidly expanding Asia Pacific region. 

Icon and Parexel: Pfizer-AZ merger will bring more business for CROs

05-May-2014 - A mega-merger between Pfizer and AstraZeneca would bring increased business to CROs say Icon and Parexel, if past experiences are to go by.

Orphan drug market offers opportunities for direct-to-patient logistics firms

29-Apr-2014 - As regulators incentivise the development of orphan medicines and high price tags for the drugs continue to rise, logistics specialists are offering new ways to get the drugs to the...

Harlan partners with Invenium to move further into Asia-Pacific region

28-Apr-2014 - Toxicology services provider Harlan Laboratories has selected Invenium Pharmacology as its exclusive agent for Harlan’s Contract Research Services (CRS) in Australia, Southeast Asia and New Zealand.

AmerisourceBergen growing global presence; first World Courier, now Proforma

28-Apr-2014 - A stake in Brazil-based wholesaler Profarma will increase AmerisourceBergen’ global presence already strengthened by the World Courier acquisition, the firm says as it reports a robust Q2.

Japanese pharma using more CROs as large-scale development picks up

24-Apr-2014 - A new report says the Japanese CRO market is seeing more growth as Japanese pharma firms, which traditionally kept research in-house, are now broadening their horizons to use more outsourcing...

News in brief

Bristol-Myers Squibb extends deal with DKSH in SE Asia

08-Apr-2014 - Bristol-Myers Squibb has extended its partnership with DKSH to provide commercialization and distribution services across Southeast Asia.

Quality and IP issues driving sponsors away from Indian CMOs, experts say

01-Apr-2014 - Quality and IP issues are driving firms back to the US and Europe for their contract manufacturing according to experts, but Kemwell says there are still opportunities for Indian CMOs.

AmerisourceBergen to launch $100m distribution JV in Brazil

25-Mar-2014 - AmerisourceBergen (ABC) plans to buy a minority stake in a Brazilian drug wholesaler and outlined plans for a $100m distribution services joint-venture in the rapidly expanding market.

Aesica predicts more CMO consolidation and hints at acquisitions

17-Mar-2014 - Aesica has predicted that CMO sector consolidation will continue and hinted that it is considering strategic acquisitions as a part of a bid to generate $1bn revenue.

breaking news - update 2

CRL to buy Argenta and Biofocus from Galapagos for €134m

13-Mar-2014 - Preclinical CRO Charles River Labs has announced plans to buy discovery services firms Argenta and BioFocus from Galapagos NV.

CDSCO analysis reveals prevalence of substandard drugs in India

11-Mar-2014 - Nearly a quarter of drugs made in Jammu & Kashmir and 10% of those produced in Himachal Pradesh are substandard according to new testing data published by CDSCO. 

WuXi reveals steep increase in quarterly manufacturing revenues

10-Mar-2014 - WuXi PharmaTech has revealed that demand for its manufacturing services increased significantly last year and forecast that its "open access" approach will help it sustain growth into 2014. 

Exclusive interview

INC Research expands into Middle East with MEK acquisition

10-Mar-2014 - In a sign of further consolidation, CRO INC Research has acquired CRO MEK Consulting and will absorb its more than 40 employees based in the Middle East and north Africa.

Demand for labs that can handle deadly viruses is catching says TNO

03-Mar-2014 - Scientists developing vaccines for potentially deadly diseases like influenza, SARS and HIV struggle to find a CRO with the right capabilities according to contractor TNO Triskelion.

PPD deals to increase presence in expanding German trials sector

25-Feb-2014 - CRO Pharmaceutical Product Development (PPD) and the Charité – Universitätsmedizin hospital in Berlin are collaborating to increase the volume of clinical trials conducted in Germany.

Icon: FY13 bolstered by M&A strategy, bolt-on acqusitions to continue

24-Feb-2014 - Icon says it intends to continue its M&A strategy focusing on capabilities, geographies and technologies as it reports a robust 2013.

DKSH gets the Glory citing increased demand for Asian expansion services

19-Feb-2014 - DKSH has acquired Macau-based distributor Glory and says demand for Asian market access is being driven from both Western and local pharma firms.

Parexel tops analysts’ revenue, EPS expectations for Q2

03-Feb-2014 - Parexel narrowly beat investment analysts’ earnings per share and revenue expectations as consolidated service revenue hit $487.1m.

Quintiles says size matters when it comes to strategic deals

22-Jan-2014 - CEO Tom Pike emphasised Quintiles’ credentials as a Big Pharma collaborator and highlighted personalised medicines as a key driver for the CRO at an investment conference last week.

AMRI targeting higher tech manufacturing and generics as Burlington booms

20-Jan-2014 - AMRI says it intends to expand its fill/finish capability and progress its business into higher value technology following the recent all clear at its once troubled Burlington facility.

CRL looks to strategic alliances to drive growth across changing clientbase

20-Jan-2014 - Strategic relationships with both big pharma and mid-tier firms will drive future growth, says Charles River laboratories (CRL).

Wuxi slightly raises financial expectations for 2013

20-Jan-2014 - WuXi PharmaTech has raised its 2013 financial guidance and now expects to achieve total revenues for 2013 of approximately $578m (€424m). 

AMEC to expand pharma plant design biz with $3bn Foster Wheeler buy

13-Jan-2014 - AMEC has announced its plan to buy US  firm Foster Wheeler AG for $3.2bn (€2.3bn) in a deal that includes the latter’s pharmaceutical plant design services business.

Recipharm to sell drug co-developed with Astimex, signs new manufacturing deal

18-Dec-2013 - CMO Recipharm has set out to sell a new own-brand infectious disease medication it developed in partnership with fellow Sweden-based firm Astimex Pharma.